Target Price | $246.59 |
Price | $239.36 |
Potential | 3.02% |
Number of Estimates | 41 |
41 Analysts have issued a price target Apple 2026 . The average Apple target price is $246.59. This is 3.02% higher than the current stock price. The highest price target is $325.00 35.78% , the lowest is $183.00 23.55% . | |
A rating was issued by 52 analysts: 31 Analysts recommend Apple to buy, 16 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Apple stock has an average upside potential 2026 of 3.02% . Most analysts recommend the Apple stock at Purchase. |
41 Analysts have issued a sales forecast Apple 2025 . The average Apple sales estimate is $411b . This is 4.99% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $432b 10.42% , the lowest is $385b 1.60% .
This results in the following potential growth metrics:
2024 | $391b | 2.02% |
---|---|---|
2025 | $411b | 4.99% |
2026 | $443b | 7.99% |
2027 | $469b | 5.80% |
2028 | $485b | 3.41% |
2029 | $483b | 0.41% |
20 Analysts have issued an Apple EBITDA forecast 2025. The average Apple EBITDA estimate is $143b . This is 6.05% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $147b 9.53% , the lowest is $134b 0.27% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $135b | 7.03% |
---|---|---|
2025 | $143b | 6.05% |
2026 | $155b | 8.50% |
2027 | $166b | 6.98% |
2028 | $174b | 4.93% |
2024 | 34.44% | 4.91% |
---|---|---|
2025 | 34.79% | 1.02% |
2026 | 34.95% | 0.46% |
2027 | 35.34% | 1.12% |
2028 | 35.86% | 1.47% |
44 Apple Analysts have issued a net profit forecast 2025. The average Apple net profit estimate is $111b . This is 20.82% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $119b 29.32% , the lowest is $101b 10.54% .
This results in the following potential growth metrics and future Net Margins:
2024 | $91.9b | 0.82% |
---|---|---|
2025 | $111b | 20.63% |
2026 | $124b | 12.11% |
2027 | $136b | 9.76% |
2028 | $145b | 6.26% |
2029 | $146b | 0.94% |
2024 | 23.50% | 2.78% |
---|---|---|
2025 | 27.01% | 14.92% |
2026 | 28.03% | 3.78% |
2027 | 29.08% | 3.75% |
2028 | 29.89% | 2.79% |
2029 | 30.29% | 1.34% |
44 Analysts have issued a Apple forecast for earnings per share. The average Apple <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $7.33 . This is 20.76% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $7.85 29.32% , the lowest is $6.71 10.54% .
This results in the following potential growth metrics and future valuations:
2024 | $6.08 | 0.82% |
---|---|---|
2025 | $7.33 | 20.56% |
2026 | $8.22 | 12.14% |
2027 | $9.02 | 9.73% |
2028 | $9.59 | 6.32% |
2029 | $9.68 | 0.94% |
Current | 39.43 | 25.61% |
---|---|---|
2025 | 32.64 | 17.22% |
2026 | 29.11 | 10.81% |
2027 | 26.52 | 8.90% |
2028 | 24.96 | 5.88% |
2029 | 24.73 | 0.92% |
Based on analysts' sales estimates for 2025, the Apple stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 8.90 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 8.77 .
This results in the following potential growth metrics and future valuations:
Current | 9.34 | 17.78% |
---|---|---|
2025 | 8.90 | 4.72% |
2026 | 8.24 | 7.40% |
2027 | 7.79 | 5.48% |
2028 | 7.53 | 3.30% |
2029 | 7.56 | 0.41% |
Current | 9.21 | 18.59% |
---|---|---|
2025 | 8.77 | 4.75% |
2026 | 8.12 | 7.40% |
2027 | 7.67 | 5.48% |
2028 | 7.42 | 3.30% |
2029 | 7.45 | 0.41% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.